Pulmonx Corporation (LUNG) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
LUNG Revenue Growth
Revenue Breakdown
LUNG's revenue distribution by segment and geography
By Geography
LUNG Revenue Analysis (2018–2025)
As of May 8, 2026, Pulmonx Corporation (LUNG) generated trailing twelve-month (TTM) revenue of $90.5 million, reflecting slight decline in growth of -4.9% year-over-year. The most recent quarter (Q4 2025) recorded $22.6 million in revenue, up 5.1% sequentially.
Looking at the longer-term picture, LUNG's 5-year compound annual growth rate (CAGR) stands at +22.6%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $90.5 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including INSP (+8.9% YoY), NVCR (+8.5% YoY), and ATRC (+15.0% YoY), LUNG has underperformed the peer group in terms of revenue growth. Compare LUNG vs INSP →
LUNG Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| LUNGCurrent | $90M | -4.9% | +22.6% | -59.3% | |
 INSP | $912M | +8.9% | +51.2% | 5.6% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% | |
 ATRC | $535M | +15.0% | +20.9% | -0.6% | |
 PRCT | $308M | +29.3% | +109.0% | -33.7% | |
 MMSI | $1.5B | +11.2% | +9.5% | 12.2% |
LUNG Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $90.5M | +8.0% | $67.1M | 74.2% | $-53,663,000 | -59.3% |
| 2024 | $83.8M | +22.0% | $62.0M | 74.0% | $-57,704,000 | -68.9% |
| 2023 | $68.7M | +28.0% | $50.8M | 73.9% | $-61,935,000 | -90.2% |
| 2022 | $53.7M | +10.8% | $39.9M | 74.3% | $-58,637,000 | -109.3% |
| 2021 | $48.4M | +47.9% | $35.6M | 73.6% | $-47,304,000 | -97.7% |
| 2020 | $32.7M | +0.4% | $21.2M | 64.8% | $-32,332,000 | -98.8% |
| 2019 | $32.6M | +62.9% | $22.4M | 68.8% | $-17,838,000 | -54.7% |
| 2018 | $20.0M | - | $12.3M | 61.4% | $-15,052,000 | -75.2% |
See LUNG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LUNG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LUNG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLUNG — Frequently Asked Questions
Quick answers to the most common questions about buying LUNG stock.
Is LUNG's revenue growth accelerating or slowing?
LUNG revenue growth slowed to -4.9%, below the 5-year CAGR of +22.6%. TTM revenue is $90M. The deceleration marks a shift from historical growth rates.
What is LUNG's long-term revenue growth rate?
Pulmonx Corporation's 5-year revenue CAGR of +22.6% reflects the variable expansion pattern. Current YoY growth of -4.9% is near this long-term average.
How is LUNG's revenue distributed by segment?
LUNG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.